1. Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer. Issue 15 (15th June 2018) Authors: Sanoff, Hanna K.; Goldberg, Richard M.; Ivanova, Anastasia; O'Reilly, Seamus; Kasbari, Samer S.; Kim, Richard D.; McDermott, Ray; Moore, Dominic T.; Zamboni, William; Grogan, William; Cohn, Allen Lee; Bekaii‐Saab, Tanios S.; Leonard, Gregory; Ryan, Theresa; Olowokure, Olugbenga O.; Fernando, Nish... Journal: Cancer Issue: Volume 124:Issue 15(2018) Page Start: 3118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗